0001209191-20-019349.txt : 20200316
0001209191-20-019349.hdr.sgml : 20200316
20200316175344
ACCESSION NUMBER: 0001209191-20-019349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200312
FILED AS OF DATE: 20200316
DATE AS OF CHANGE: 20200316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doyle Noah
CENTRAL INDEX KEY: 0001631673
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 20718508
MAIL ADDRESS:
STREET 1: C/O RITTER PHARMACEUTICALS INC.
STREET 2: 1801 CENTURY PARK EAST, SUITE 1820
CITY: LOS ANGELES
STATE: CA
ZIP: 90096
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 310-203-1000
MAIL ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-12
0
0001460702
RITTER PHARMACEUTICALS INC
RTTR
0001631673
Doyle Noah
RITTER PHARMACEUTICALS, INC.
1880 CENTURY PARK EAST, SUITE 1000
LOS ANGELES
CA
90067
1
0
0
0
Common Stock
2020-03-12
4
S
0
500000
0.22
D
704780
I
By Javelin Partners, L.P.
Common Stock
32275
I
By Javelin Venture Partners I SPV I, LLC
Common Stock
2272
D
The Reporting Person sold the securities in open market transactions at prices ranging from $0.22 to $0.23 per share, with a weighted average sale price of $0.22 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer or a securityholder of the issuer, full information regarding the number of shares sold at each separate price.
As the managing director of Javelin Partners, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.
As the managing director of Javelin Venture Partners I SPV I, LLC, the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.
/s/ Noah Doyle
2020-03-16